BIOLASE Inc. (BIOL): שווי שוק להכנסות
BIOLASE, Inc. (BIOL) ensures precision equipment assembly in compliance with RoHS standards. The cost-to-sales ratio reflects the current market valuation, where the parameter is 0.00. Leadership in the painless treatment niche with Waterlase makes the brand's systems highly sought after in premium clinics, while the implementation of energy-efficient production cycles and the minimization of plastic confirm the company's commitment to environmental responsibility.
פילוחים אנליטיים של חברת Biolase, Inc. (BIOL)
The P/S multiple determines the market value of one dollar of revenue, allowing an investor to assess the degree of overpayment for a business regardless of current profitability. By analyzing the price-to-sales ratio, one can understand the premium at which the market values the leadership of BIOLASE (BIOL) in the painless dental laser segment and the willingness of capital to pay for exceptional brand authority.
